Blog

Teva Pharmaceutical offers to buy Mylan for $40.1 bn

Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium

Teva Pharmaceutical offers to buy Mylan for $40.1 bn

Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium

Another study finds no link between vaccine, autism

Yet another scientific study has found no link between autism and the vaccine against measles, mumps and rubella (MMR), according to US research published on Tuesday. The findings in the Journal of the American Medical Association (JAMA) are based on a study of about 95,000 children with older siblings, some of whom had autism spectrum disorder (ASD). “Consistent with studies in other populations, we observed no association between MMR vaccination

Another study finds no link between vaccine, autism

Yet another scientific study has found no link between autism and the vaccine against measles, mumps and rubella (MMR), according to US research published on Tuesday. The findings in the Journal of the American Medical Association (JAMA) are based on a study of about 95,000 children with older siblings, some of whom had autism spectrum disorder (ASD). “Consistent with studies in other populations, we observed no association between MMR vaccination

New U.S. mammogram guidelines stick with screening from age 50

By Julie Steenhuysen CHICAGO (Reuters) – New mammogram screening guidelines from an influential panel of U.S. experts reaffirm earlier guidance that breast cancer screening should begin at age 50 for most women, but they acknowledge that women in their 40s also benefit, something experts say is a step in the right direction. “They made it really clear this time around, unlike 2009, that the discussion between a woman and a clinician

New U.S. mammogram guidelines stick with screening from age 50

By Julie Steenhuysen CHICAGO (Reuters) – New mammogram screening guidelines from an influential panel of U.S. experts reaffirm earlier guidance that breast cancer screening should begin at age 50 for most women, but they acknowledge that women in their 40s also benefit, something experts say is a step in the right direction. “They made it really clear this time around, unlike 2009, that the discussion between a woman and a clinician